CTYX Connectyx Technologies Holding

Connectyx Technologies Holdings Group, Inc. Announces Definitive Agreement with Mid-Atlantic BioTherapeutics, Inc. for Treatment of Symptomatic Rabies

Connectyx Technologies Holdings Group, Inc. Announces Definitive Agreement with Mid-Atlantic BioTherapeutics, Inc. for Treatment of Symptomatic Rabies
EN
09/10/2020

Underlying

CTYXConnectyx Technologies Holding

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Connectyx Technologies Holding

 PRESS RELEASE
Free
CTYX Connectyx Techn...

Curative Biotechnology, Inc. Engages Golden Eagle Capital Advisors, In...

Curative Biotechnology, Inc. Engages Golden Eagle Capital Advisors, Inc. as Exclusive Agent and Strategic Advisor Palm Beach Gardens, FL, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases today announced the engagement of Golden Eagle Capital Advisors, Inc (“GECA”), a financial advisory group based in Dubai as the exclusive agent and strategic advisor to the company. About Golden Eagle Capital Advisors, Inc. GOLDEN EAGLE CAPITAL...

December 13, 2024 1 EN
 PRESS RELEASE
Free
CTYX Connectyx Techn...

Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah ...

Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors Palm Beach Gardens, FL, March 22, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases today announced the nomination to its Board of Directors of Dr. Theresa Heah. Dr. Heah is expected to join its Board of Directors immediately as an independent director. In addition to other Board duties Dr. Heah will serve on the newly created Clinical Development Co...

March 22, 2024 1 EN
 PRESS RELEASE
Free
CTYX Connectyx Techn...

Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah ...

Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors Appointment of Independent Director Nominee to become effective upon approval by and listing of common stock on a National Exchange Boca Raton, FL, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases today announced its nomination to its Board of Directors of Dr. Theresa Heah. Dr. Heah is expected to join its Board of Directors as an indepe...

January 8, 2024 1 EN
 PRESS RELEASE
Free
CTYX Connectyx Techn...

Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebm...

Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors Appointment of Independent Director to become effective upon approval by and listing of common stock on a National Exchange Boca Raton, FL, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases today announced its nomination to its Board of Directors of Dr. Jeffrey Liebmann. Dr. Liebmann is expected to join its Board of Directors as an inde...

October 31, 2023 1 EN
 PRESS RELEASE
Free
CTYX Connectyx Techn...

Curative Biotechnology Announces Establishment of Japanese Subsidiary ...

Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions Appoints Paul Michaels Co-CEO of Parent and CEO of Subsidiary Boca Raton, FL, June 06, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel therapies for rare diseases and conditions, today announced that the registration process has begun for the creation of a subsidiary in Japan with an official incorporation date expected August 1, 2023, to facilitate licensin...

June 6, 2023 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch